Literature DB >> 15610676

'Flat-fixed dosing' of chemotherapy: a concept whose time has come?

Maurie Markman.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15610676     DOI： 10.1007/s11912-005-0014-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  8 in total

1.  Ethnographic study of incidence and severity of intravenous drug errors.

Authors:  Katja Taxis; Nick Barber
Journal:  BMJ       Date:  2003-03-29

Review 2.  Common errors of drug administration in infants: causes and avoidance.

Authors:  B J Anderson; J F Ellis
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

3.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

Authors:  L L Leape; T A Brennan; N Laird; A G Lawthers; A R Localio; B A Barnes; L Hebert; J P Newhouse; P C Weiler; H Hiatt
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

4.  Preventing adverse drug events.

Authors:  L L Leape
Journal:  Am J Health Syst Pharm       Date:  1995-02-15       Impact factor: 2.637

5.  Drug errors in intensive care.

Authors:  L A Bordun; W Butt
Journal:  J Paediatr Child Health       Date:  1992-08       Impact factor: 1.954

6.  Flat-fixed dosing of irinotecan: influence on pharmacokinetic and pharmacodynamic variability.

Authors:  Floris A de Jong; Ron H J Mathijssen; Rujia Xie; Jaap Verweij; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

7.  Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.

Authors:  H P Gurney; S Ackland; V Gebski; G Farrell
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

8.  How to calculate the dose of chemotherapy.

Authors:  Howard Gurney
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640
  8 in total
  1 in total

1.  Dose standardisation of anticancer drugs.

Authors:  Anne-Lise Pouliquen; Laurence Escalup; Nathalie Jourdan; Paul Cottu; Pierre Faure; Isabelle Madelaine-Chambrin
Journal:  Int J Clin Pharm       Date:  2011-01-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.